News

Filter

Germany's IQWiG finds in favor of Yervoy but not Benlysta or Fampyra

09-05-2012

The German Institute for Quality and Efficiency in Health Care (IQWiG) in the past few days issued a…

BenlystaBiogen IdecBiotechnologyBristol-Myers SquibbEuropeFampyraGlaxoSmithKlineNeurologicalOncologyPharmaceuticalPricingRare diseasesRegulationYervoy

Slew of good news from EMA advisory panel for Benlysta, Fampyra, Vibativ, Victrelis, Xgeva and Yervoy

23-05-2011

Friday proved to be a good day for some of the world’s leading drugmakers, as the European Medicines…

AmgenAnti-viralsAntibiotics and Infectious diseasesAstellas PharmaBenlystaBiogen IdecBiotechnologyBristol-Myers SquibbEuropeFampyraGlaxoSmithKlineHuman Genome SciencesMerck & CoNeurologicalOncologyPharmaceuticalRare diseasesRegulationVibativVictrelisXgevaYervoy

Merck Serono resubmits cladribine as a potential MS therapy in USA; GSK/HGS file Benlysta in Europe

08-06-2010

Putting it back in the race to get US approval for an oral multiple sclerosis treatment, Merck Serono,…

BenlystaCladribineGlaxoSmithKlineHuman Genome SciencesImmunologicalsMerck KGaAMerck SeronoNeurologicalPharmaceuticalRegulation

COMPANY SPOTLIGHT

Menarini

Back to top